Table 12: Clinical Variables at 3 and 6 Months Follow-Up.
| ECT group | rTMS group | t | df | C-I | p | |
|---|---|---|---|---|---|---|
| X ± SD | X ± SD | |||||
| (n=20) | (n=21) | |||||
| HRSD post 3 month | 7.71 ± 5.03 | 6.40 ± 4.91 | .846 | 39 | –1.83, 4.46 | NS |
| GAS post 3 month | 75.52 ± 13.81 | 79.75 ± 12.92 | –1.01 | 39 | –12.69, 4.23 | NS |
| HRSD post 6 month | 8.40 ± 5.60 | 7.90 ± 7.14 | .246 | 39 | –3.61, 4.61 | NS |
| GAS post 6 month | 72.80 ± 11.94 | 77.75 ± 17.13 | –1.06 | 39 | –14.40, 4.50 | NS |
| MATS 3 month | 1.92 ± 1.04 | 2.28 ± 1.07 | –.92 | 29 | –1.14,.43 | NS |
| MATS 6 month | 1.82 ± 0.98 | 2.44 ± 1.03 | –1.563 | 25 | –1.44,.20 | NS |
ECT, electroconvulsive therapy; GAS, Global Assessment Scale; HRSD, Hamilton Rating Scale for Depression; MATS, Michigan Adequacy of Treatment; rTMS, repetitive transcranial magnetic stimulation.
Reprinted from Biological Psychiatry, 51(8), Dannon PN, Dolberg OT, Schreiber S, Grunhaus L. Three and six-month outcome following courses of either ECT or rTMS in a population of severely depressed individuals—preliminary report. Biological Psychiatry, 687-690, Copright 2002, with permission from the Society of Biological Psychiatry (6)